'Enough is enough': British PM calls for tougher anti-terror measures

June 5, 2017

London, Jun 5: British Prime Minister Theresa May has called for stronger counter-terrorism measures following Saturday's killing spree on the streets of London — the third deadly terror attack in the UK in less than three months.

anti terror

Three attackers drove a hired van into pedestrians on London Bridge and stabbed others nearby, killing seven people and wounding 48, before the assailants were shot dead by police.

“It is time to say enough is enough,” May said in a statement outside her Downing Street office on Sunday.

“We cannot and must not pretend that things can continue as they are,” she added, calling for new measures that could include longer jail sentences for some offenses and new cyberspace regulations.

May said the series of attacks in the UK were not connected in terms of planning and execution, but were inspired by what she called a “single, evil ideology of Islamist extremism” that represented a perversion of Islam and of the truth.

“While we have made significant progress in recent years, there is — to be frank — far too much tolerance of extremism in our country,” she said, urging Britons to be more robust in stamping it out in society.

King Salman sent a cable of condolences to May.

“We have received the news of the terrorist attack that took place in London, which resulted in deaths and injuries,” King Salman said.

The Muslim World League (MWL) condemned the terrorist attack.

MWL Secretary-General Mohammed bin Abdul Karim Al-Issa stressed upon the league's consistent position toward terrorism and its supporters.

Terrorists aim to target the UK's excellence as a model of tolerance and human coexistence, he said, adding that these groups' ideology includes exporting their misery and despair as well as attacking the values of this civilized state in order to create a civilizational and cultural conflict.

Daesh claimed responsibility for the London attack.

One analyst on terrorism told Arab News the incident comes at a time when Daesh is stepping up attacks on global targets.

Peter Lehr, lecturer in Terrorism Studies at the Center for the Study of Terrorism and Political Violence at St. Andrews University, Scotland, pointed to a previous call by Daesh spokesman Abu Mohammed Al-Adnani, who urged followers to attack Western targets by any means necessary.

“Smash his head with a rock, or slaughter him with a knife, or run him over with your car, or throw him from a high place,” Al-Adnani said in 2014.

Lehr said: “This attack perfectly fits the bill. What is important in this regard is that unlike the Manchester suicide bombing, carrying out such an attack doesn't require any advanced skills such as bomb making nor any lengthy preparations, that make it more likely to be discovered by intelligence (services) or police before the perpetrators are ready to strike.”

Eyewitnesses of Saturday's terror atrocity described harrowing scenes as the attackers' white van veered on and off the bridge sidewalk, hitting people along the way. The three men then ran into an area packed with bars and restaurants, stabbing people indiscriminately.

One eyewitness told Arab News that she saw a man with his throat cut stumbling away from the scene. “We saw a man coming off the bridge with blood all over him and it looked like he had his throat slashed,” she said. “He was holding his neck.”

Mark Rowley, head of counter-terrorism police, said eight officers had fired about 50 bullets to stop the attackers, who were wearing what turned out to be fake suicide vests.

Police on Sunday arrested 12 people in east London, where at least one of the attackers is believed to have resided, according to Sky News.

Saturday's attack came five days before the UK parliamentary election on Thursday, which May said would go ahead as planned. The string of terror attacks in the UK is likely to be central issue of debate in the last few days of campaigning.

Around two weeks ago, a suicide bomber killed 22 children and adults at a concert by US singer Ariana Grande in Manchester in northern England. In March, in an attack similar to Saturday's, five people died after a man drove into pedestrians on Westminster Bridge in central London and stabbed a policeman.

World leaders, including those from the Middle East, were quick to condemn the recent attacks in London.

An official source at Saudi Arabia's Ministry of Foreign Affairs expressed the Kingdom's “strong condemnation and denunciation of the attacks.”

In a statement to the Saudi Press Agency, the source offered the Kingdom's condolences to the families of the victims and to the UK government and people, wishing a speedy recovery to the wounded.

The official source reiterated the “Kingdom's solidarity with the United Kingdom against terrorism and extremism which target security and stability around the world without exception.”

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
May 19,2020

Washington DC, May 19: US President Donald Trump has threatened to permanently halt funding for the World Health Organisation (WHO) if it did not commit to improvements within 30 days, and to reconsider the membership of the United States in the global health body.

On Monday, Trump wrote a letter to WHO Director-General Tedros Ghebreyesus that read, "If WHO doesn't commit to major substantive improvements within the next 30 days, I will make my temporary freeze of US funding to WHO permanent and reconsider our membership in the organisation."

Trump had temporarily suspended US' contribution to the WHO last month, accusing it of promoting China's "disinformation" about the coronavirus outbreak, although WHO officials denied the accusation and Beijing said that it was transparent and open.

"The only way forward for the WHO is if it can actually demonstrate independence from China. My administration has already started discussions with you on how to reform the organisation. But action is needed quickly. 

We do not have time to waste," Trump said in the letter.

"I cannot allow American taxpayer dollars to continue to finance an organisation that, in its present state, is so clearly not serving America's interests," he added.

On Monday, the WHO said that an independent review of the global coronavirus response would begin at the earliest and it received backing from China, where the virus was first discovered.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 10,2020

Melbourne, Apr 10: Scientists have identified six drug candidates from more than 10,000 compounds that may help treat COVID-19.

The research, published in the journal Nature, tested the efficacy of approved drugs, drug candidates in clinical trials and other compounds.

"Currently there are no targeted therapeutics or effective treatment options for COVID-19," said Professor Luke Guddat from the University of Queensland in Australia.

"In order to rapidly discover lead compounds for clinical use, we initiated a programme of high-throughput drug screening, both in laboratories and also using the latest computer software to predict how different drugs bind to the virus," Guddat said.

The project targeted the main COVID-19 virus enzyme, known as the main protease or Mpro, which plays a pivotal role in mediating viral replication, the researchers said.

This makes it an attractive drug target for this virus, and as people don't naturally have this enzyme, compounds that target it are likely to have low toxicity, they said.

"We add the drugs directly to the enzyme or to cell cultures growing the virus and assess how much of each compound is required to stop the enzyme from working or to kill the virus. If the amount is small, then we have a promising compound for further studies," said Guddat.

After assaying thousands of drugs, researchers found of the six that appear to be effective in inhibiting the enzyme, one is of particular interest.

"We're particularly looking at several leads that have been subjected to clinical trials including for the prevention and treatment of various disorders such as cardiovascular diseases, arthritis, stroke, atherosclerosis and cancer," Guddat said.

Researchers said compounds that are already along the pipeline to drug discovery are preferred, as they can be further tested as antivirals at an accelerated rate compared to new drug leads that would have to go through this process from scratch.

"With continued and up-scaled efforts we are optimistic that new candidates can enter the COVID-19 drug discovery pipeline in the near future," Guddat said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 25,2020

Beijing, Mar 25: Around 5,000 people have signed up for the phase I clinical trial of recombinant novel coronavirus vaccine in Chinese city Wuhan where the virus first emerged late last year.

The recruitment for participants ended this week with nearly 5,000 volunteers signing up for the trial, state-run Beijing News reported on Wednesday.

A single-centre, open and dose-escalation phase I clinical trial for recombinant novel coronavirus vaccine (adenoviral vector) will be tested in healthy adults aged between 18 and 60 years, according to the ChiCTR (China Clinical Trial Register).

The trial, led by experts from the Academy of Military Medical Sciences, gained its approval on March 16 and the research is expected to last half a year.

Requiring at least 108 participants, the trial will be conducted in Wuhan, capital of Hubei province, the region worst-affected by the virus in the country, state-run China Daily reported.

Participants will experience 14-day quarantine restrictions after being vaccinated and their health condition will be recorded every day.

Chinese scientists are hastening the development of COVID-19 vaccines through five approaches --- inactivated vaccines, genetic engineering subunit vaccines, adenovirus vector vaccines, nucleic acid vaccines and vaccines using attenuated influenza virus as vectors.

So far, most teams are expected to complete preclinical research in April and some are moving forward faster, Wang Junzhi, an academician with the Chinese Academy of Engineering said.

Wang noted that research and development of COVID-19 vaccines in China is not slower than foreign counterparts and has been carried out in a scientific, standardised and orderly way.

China has stepped up the process to finalise vaccines to counter COVID-19 after Kaiser Permanente research facility in Seattle and Washington stole the march and began human trials.

China lifted tough restrictions on the Hubei province on Wednesday after a months-long lockdown as the country reported no new domestic cases.

But there were another 47 imported infections from overseas, the National Health Commission said. In total, 474 imported infections have been diagnosed in China -- mostly Chinese nationals returning home.

Comments

Y UDAYA CHANDAR
 - 
Monday, 13 Apr 2020

Dear Sir,

 

I am 77 but a very healthy person with remarkable immunity. I contracted Malaria fever in 1994 because of mosquito biting and I have not been sick anytime there after, not even for ordinary fever in the last 26 years.

 

I am sure you would like to conduct the trials on persons of varying criteria. I am sure you don't want to carry out the trials on perfectly healthy young individuals only. 

 

I am certain that  you want to try the vaccine on a 'common man' from 'general public.' I am ready for the trial and you can take me. I will be delighted. 

 

If you are not handling this matter kindly forward this mail to the correct agency.

 

I look forward to hearing from you.

 

Best regards.

 

If you are not moving forward, you are really moving backward.

Y Udaya Chandar

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.